Uranium Royalty Statistics
Total Valuation
UROY has a market cap or net worth of $281.35 million. The enterprise value is $273.61 million.
| Market Cap | 281.35M |
| Enterprise Value | 273.61M |
Important Dates
The last earnings date was Friday, March 15, 2024, after market close.
| Earnings Date | Mar 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UROY has 120.24 million shares outstanding. The number of shares has increased by 21.64% in one year.
| Shares Outstanding | 120.24M |
| Shares Change (YoY) | +21.64% |
| Shares Change (QoQ) | +9.47% |
| Owned by Insiders (%) | 17.43% |
| Owned by Institutions (%) | 15.28% |
| Float | 99.26M |
Valuation Ratios
The trailing PE ratio is 53.64 and the forward PE ratio is 156.25.
| PE Ratio | 53.64 |
| Forward PE | 156.25 |
| PS Ratio | 8.50 |
| Forward PS | n/a |
| PB Ratio | 1.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 55.26 |
| EV / Sales | 8.27 |
| EV / EBITDA | 69.05 |
| EV / EBIT | 69.29 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 244.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 244.30 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | n/a |
| Interest Coverage | 15.17 |
Financial Efficiency
Return on equity (ROE) is 3.20% and return on invested capital (ROIC) is 3.05%.
| Return on Equity (ROE) | 3.20% |
| Return on Assets (ROA) | 3.20% |
| Return on Capital (ROIC) | 3.05% |
| Revenue Per Employee | $2.54M |
| Profits Per Employee | $380,884 |
| Employee Count | 13 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 0.24 |
Taxes
| Income Tax | -1.14M |
| Effective Tax Rate | -29.76% |
Stock Price Statistics
The stock price has increased by +17.00% in the last 52 weeks. The beta is 1.66, so UROY's price volatility has been higher than the market average.
| Beta (1Y) | 1.66 |
| 52-Week Price Change | +17.00% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 2.66 |
| Relative Strength Index (RSI) | 39.86 |
| Average Volume (30 Days) | 1,703,262 |
Short Selling Information
The latest short interest is 1.91 million, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 1.91M |
| Short Previous Month | 1.98M |
| Short % of Shares Out | 1.59% |
| Short % of Float | 1.93% |
| Short Ratio (days to cover) | 1.14 |
Income Statement
In the last 12 months, UROY had revenue of $33.08 million and earned $4.95 million in profits. Earnings per share was $0.04.
| Revenue | 33.08M |
| Gross Profit | 9.30M |
| Operating Income | 4.07M |
| Pretax Income | 3.69M |
| Net Income | 4.95M |
| EBITDA | 3.96M |
| EBIT | 3.95M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $7.89 million in cash and $147,588 in debt, giving a net cash position of $7.74 million or $0.06 per share.
| Cash & Cash Equivalents | 7.89M |
| Total Debt | 147,588 |
| Net Cash | 7.74M |
| Net Cash Per Share | $0.06 |
| Equity / Book Value | 174.72M |
| Book Value Per Share | 1.45 |
| Working Capital | 140.98M |
Cash Flow
In the last 12 months, operating cash flow was -$68.20 million and capital expenditures -$1.48 million, giving a free cash flow of -$69.68 million.
| Operating Cash Flow | -68.20M |
| Capital Expenditures | -1.48M |
| Free Cash Flow | -69.68M |
| FCF Per Share | -$0.62 |
Margins
Gross margin is 28.11%, with operating and profit margins of 12.31% and 14.97%.
| Gross Margin | 28.11% |
| Operating Margin | 12.31% |
| Pretax Margin | 11.15% |
| Profit Margin | 14.97% |
| EBITDA Margin | 11.98% |
| EBIT Margin | 11.94% |
| FCF Margin | -210.62% |
Dividends & Yields
UROY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.64% |
| Shareholder Yield | -21.64% |
| Earnings Yield | 1.76% |
| FCF Yield | -24.77% |
Analyst Forecast
The average price target for UROY is $7.70, which is 229.06% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.70 |
| Price Target Difference | 229.06% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UROY has an Altman Z-Score of 242.44 and a Piotroski F-Score of 3.
| Altman Z-Score | 242.44 |
| Piotroski F-Score | 3 |